Home
Sign In
About
Curriculum
Activity Information
Target Audience
Learning Objectives
Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.
Course materials have been developed for use outside of the United States.
|
 |
|
|
|
|
|
|
Iron Toxicity and Clinical Sequelae
Iron overload can occur with a variety of conditions, resulting in significant clinical morbidity. The risk factors, mechanisms contributing to the development of iron overload, and resulting clinical consequences on the liver, heart, and endocrine system are discussed by Dr. John Porter in this webcast.
|
|
Faculty
|
|
|
John B. Porter, MA, MD, FRCP
Professor, Department of Haematology
University College London
London, United Kingdom
|
|
|
Target Audience
This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
|
Learning Objectives
After participating in this activity, participants should be better able to:
- Analyze the mechanisms contributing to the development of iron overload and the clinical consequences of iron overload on the liver, heart, and endocrine system.
- Utilizing an understanding of the factors contributing to the development of iron overload, identify patients at risk in the practice setting.
|
Disclosure Information
John B. Porter, MA, MD, FRCP, has received grant/research support from and is on the speakers bureau of Novartis Pharmaceuticals Corporation; and is a consultant for Genzyme Corporation, Resonance Health Ltd, and Novartis Pharmaceuticals Corporation.
|
|
|
|
|
|
|
